Skip to main content
. Author manuscript; available in PMC: 2018 Jun 15.
Published in final edited form as: Clin Cancer Res. 2016 Dec 22;23(12):2972–2980. doi: 10.1158/1078-0432.CCR-16-2349

Table 4. Clinical activity.

Parameter (n = 24) Dose escalation (n = 8/12 evaluable) Dose expansion (n = 4/6 evaluable) “B” dose escalation (n = 6/6 evaluable)
Best ORR by RECIST
 CR/PR 0 0 0
 SD 3 2 4
 PD 5 2 2
Best ORR by irRC
 CR/PR 0 0 0
 SD 6 2 3
 PD 2 2 3
GIST patients only (n = 17) n = 5/7 evaluable 4/6 evaluable 4/4 evaluable
Best ORR by Choi
  CR/PR 3 1 3
  SD 1 2 0
  PD 1 1 1

Abbreviations: ORR, overall response rate; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.